Shape Therapeutics’ Big Financing Shows Growing Interest In Novel Capsids

Horizontal image of a collection of prescription capsules and tablets in the shape of DNA running diagonally across the picture on a light green background with room for copy (text).
Shape Therapeutics said it raised $116m in a series B venture capital round • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business